Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia-Reference-Cited by-同舟云学术

Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia

Published:2000-12 Issue:12 Volume:9 Page:2889-2901
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Denny William A¹,Wilson William R¹

Affiliation:

1. Auckland Cancer Society Research Centre, Faculty of Medicine and Health Science, The University of Auckland, Private Bag 92019, Auckland 1000, New Zealand. b.denny@auckland.ac.nz

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.9.12.2889

Reference96 articles.

1. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays

2. Hypoxic regions exist in human prostate carcinoma

3. Intratumoral pO2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix

4. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor microenvironment: A playground for cells from multiple diverse origins;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

3. Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models;Molecular Oncology;2024-03

4. Injectable hydrogel-based drug delivery systems for enhancing the efficacy of radiation therapy: A review of recent advances;Chinese Chemical Letters;2023-10

5. Effectiveness of radiotherapy and targeted radionuclide therapy for melanoma in preclinical mouse models: A combination treatments overview;Bulletin du Cancer;2023-09